Evaluation of the relationships between beta-human chorionic gonadotropin (β-hCG) blood levels and pregnancy: A retrospective study
- PMID: 40735583
- PMCID: PMC12302107
- DOI: 10.12669/pjms.41.7.12250
Evaluation of the relationships between beta-human chorionic gonadotropin (β-hCG) blood levels and pregnancy: A retrospective study
Abstract
Objective: To retrospectively evaluate the relationships between beta-human chorionic gonadotropin (β-hCG) blood levels and pregnancy in primary care.
Methods: The retrospective study was conducted in Bursa Uludağ University Family Health Center in Turkey between October 1st and 31st October 2023. In the study, the data of pregnant women who applied to the Family Health Center for pregnancy examinations and follow-ups within the five years between January 1, 2018, and December 31, 2022, were taken from the database and evaluated retrospectively. History of current and previous pregnancies, sociodemographic findings, current diseases, allergies, cancer, genetic disease, Rh incompatibility, medication use, pregnancy risk factors, pregnancy complications, and delivery method and outcomes were obtained. Blood total β-hCG measurement results were examined for pregnancy and differential diagnoses. P-values below 0.05 were considered statistically significant. Analyses were made in the SPSS 25.0 program.
Results: The mean age of the 239 pregnant women who participated in the study was 28.74±4.02, and the mean total gestational age was 37.28±7.68 weeks. It was determined that 96.2% of the pregnant women had total β-hCG levels in the blood above 5 mIU/ml. Risk factors were present in 26.4% of the pregnant women, and 3.8% of them developed complications during pregnancy. Blood β-hCG levels were higher in those who had an additional disease during pregnancy, those who were on medication, those who had risk factors, and those who developed complications. While total β-hCG measurement levels were lower in those who had normal or cesarean live births, they were higher in those who had abortions (p=0.03).
Conclusion: In our study, blood β-hCG levels were higher in pregnant women who had an additional disease, those who were on medication, those who had risk factors and those who developed complications. Total β-hCG measurement levels were lower in those who had normal or cesarean live births, while they were higher in those who had abortions. Different results in blood β-hCG levels require a holistic approach to evaluate pregnancy. In this critical process, the collaboration of family physicians with obstetrics, gynecology and other clinics is important.
Keywords: complications; diseases; pregnancy; primary care; β-human chorionic gonadotropin.
Copyright: © Pakistan Journal of Medical Sciences.
Similar articles
-
FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques.Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD010042. doi: 10.1002/14651858.CD010042.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543584 Free PMC article.
-
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.Cochrane Database Syst Rev. 2014 Oct 31;2014(10):CD008046. doi: 10.1002/14651858.CD008046.pub4. Cochrane Database Syst Rev. 2014. PMID: 25358904 Free PMC article.
-
Cycle regimens for frozen-thawed embryo transfer.Cochrane Database Syst Rev. 2017 Jul 5;7(7):CD003414. doi: 10.1002/14651858.CD003414.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2025 Jun 3;6:CD003414. doi: 10.1002/14651858.CD003414.pub4. PMID: 28675921 Free PMC article. Updated.
-
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599. Online ahead of print. Clin Orthop Relat Res. 2025. PMID: 40569278
-
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18. Am J Obstet Gynecol MFM. 2022. PMID: 35728780
References
-
- Betz D, Fane K. In:StatPearls. JTreasure Island (FL): StatPearls Publishing; 2023. Aug 14, Human Chorionic Gonadotropin. - PubMed
-
- Davies S, Byrn F, Cole LA. Human chorionic gonadotropin testing for early pregnancy viability and complications. Clin Lab Med. 2003;23(2):257–64. vii. doi:10.1016/s0272-2712(03)00026-x. - PubMed
-
- Wang Z, Gao Y, Zhang D, Li Y, Luo L, Xu Y. Predictive value of serum β-human chorionic gonadotropin for early pregnancy outcomes. Arch Gynecol Obstet. 2020;301(1):295–302. doi:10.1007/s00404-019-05388-2. - PubMed
LinkOut - more resources
Full Text Sources